Medicare Enrolled
Dr. Gwendoline Menga, DO
Rheumatology · Conroe, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Menga from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menga?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Menga
Dr. Gwendoline Menga is a rheumatology specialist in Conroe, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Menga performed 283,141 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Menga received a total of $25,140 from 50 pharmaceutical and/or device companies across 1283 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Menga is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 1% volume in TX
$25,140 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗283,141
Medicare services
Top 1% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
227,200 | $4 | $20 |
| Romosozumab injection (Evenity) for osteoporosis | 21,000 | $8 | $26 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
17,820 | $10 | $55 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,900 | $34 | $131 |
| Denosumab injection (Prolia/Xgeva) | 4,140 | $18 | $46 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
1,204 | $56 | $152 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
632 | $88 | $213 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
475 | $0 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
449 | $11 | $33 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
267 | $100 | $350 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
259 | $1 | $20 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
201 | $9 | $26 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
152 | $22 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
124 | $48 | $138 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $66 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $117 | $322 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
70 | $6 | $26 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
54 | $55 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.7% high complexity
90.0% medium
0.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,140
Total received (2018-2024)
Avg $3,591/year across 7 years
Top 16% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,283
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,925
2023
$3,726
2022
$2,949
2021
$2,520
2020
$2,609
2019
$3,720
2018
$3,690
Payments by company (2024)
Janssen Biotech, Inc.
$2,481
Amgen Inc.
$625
UCB, Inc.
$616
ABBVIE INC.
$360
Organon Llc
$240
GlaxoSmithKline, LLC.
$226
AstraZeneca Pharmaceuticals LP
$217
Novartis Pharmaceuticals Corporation
$188
PFIZER INC.
$166
Johnson & Johnson Health Care Systems Inc.
$150
Mallinckrodt Hospital Products Inc.
$149
Radius Health, Inc.
$100
Lilly USA, LLC
$90
Sandoz Inc.
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Aurinia Pharma U.S., Inc.
$37
ANI Pharmaceuticals, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$28
E.R. Squibb & Sons, L.L.C.
$27
Ultragenyx Pharmaceutical Inc.
$26
Alexion Pharmaceuticals, Inc.
$26
TerSera Therapeutics LLC
$21
Kyowa Kirin, Inc.
$19
Genentech USA, Inc.
$14
Top 3 companies account for 62.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,552
Janssen Biotech, Inc.
$3,756
PFIZER INC.
$2,123
UCB, Inc.
$2,072
ABBVIE INC.
$1,469
Novartis Pharmaceuticals Corporation
$1,429
Lilly USA, LLC
$1,268
GlaxoSmithKline, LLC.
$973
E.R. Squibb & Sons, L.L.C.
$789
Mallinckrodt Hospital Products Inc.
$664
GENZYME CORPORATION
$631
AbbVie, Inc.
$597
Radius Health, Inc.
$552
AbbVie Inc.
$545
AstraZeneca Pharmaceuticals LP
$510
Genentech USA, Inc.
$472
Celgene Corporation
$365
Organon Llc
$240
Janssen Scientific Affairs, LLC
$223
Organon LLC
$206
Johnson & Johnson Health Care Systems Inc.
$150
Antares Pharma, Inc.
$145
Alexion Pharmaceuticals, Inc.
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Sandoz Inc.
$119
Horizon Therapeutics plc
$109
Hikma Pharmaceuticals USA
$106
Horizon Pharma plc
$91
Abbott Laboratories
$81
Ultragenyx Pharmaceutical Inc.
$60
Aurinia Pharma U.S., Inc.
$58
Kiniksa Pharmaceuticals, Ltd.
$54
ANI Pharmaceuticals, Inc.
$54
Iroko Pharmaceuticals, LLC
$53
TerSera Therapeutics LLC
$48
MEDEXUS PHARMA, INC.
$42
Kiniksa Pharmaceuticals International, plc
$28
MEDAC PHARMA, INC.
$27
Teva Pharmaceuticals USA, Inc.
$27
Mallinckrodt Enterprises LLC
$22
Kyowa Kirin, Inc.
$19
Mylan Institutional Inc.
$18
Exeltis, USA Inc.
$18
Gilead Sciences, Inc.
$17
Merck Sharp & Dohme Corporation
$17
Sobi, Inc
$17
West-Ward Pharmaceuticals
$16
Bioventus LLC
$15
Cumberland Pharmaceuticals, Inc.
$13
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 41.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · AXIUM · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · FORTEO · GELSYN 3 · GRANIX · HADLIMA · HUMIRA · HYRIMOZ · Humira · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OFEV · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · Proclaim IPG · Prolia · Quzyttir · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · VIVLODEX · XELJANZ · ZORVOLEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
28
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Menga is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Menga experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Menga performed 227,200 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Menga receive payments from pharmaceutical companies?
Yes. Dr. Menga received a total of $25,140 from 50 companies across 1,283 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menga's costs compare to other rheumatologists in Conroe?
Dr. Menga's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menga) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Conroe
Browse rheumatologists in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology